Hydroxyzine Pamoate
NDC 0115-1804, Hydroxyzine Pamoate, capsule, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 0115-1804
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040156
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYZINE PAMOATE50 mg/1
Pharmacologic classes
Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0115-1804-01 | 00115180401 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0115-1804-01) |
| 0115-1804-02 | 00115180402 | 500 CAPSULE in 1 BOTTLE, PLASTIC (0115-1804-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bc82aaaf-30c7-4afe-a908-d138ea1268efNADAC price for package 00115180401
GET /v1/drugs/nadac/00115180401NADAC price for package 00115180402
GET /v1/drugs/nadac/00115180402
Use it
Look up 0115-1804 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0115-1804. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.